Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Patients With Active Psoriatic Arthritis
Conditions
Interventions
Dose A VTX958
Dose B VTX958
+1 more
Locations
46
United States
Site # 840001
Phoenix, Arizona, United States
Site # 840016
Newport Beach, California, United States
Site # 840004
Clearwater, Florida, United States
Site # 840014
Miami Lakes, Florida, United States
Site # 840017
Lexington, Kentucky, United States
Site # 840018
Okemos, Michigan, United States
Start Date
January 31, 2023
Primary Completion Date
January 2, 2024
Completion Date
January 2, 2024
Last Updated
December 27, 2024
NCT07295509
NCT07286058
NCT06100744
NCT04402086
NCT06888193
NCT07315061
Lead Sponsor
Ventyx Biosciences, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions